Tamoxifen: what you should and shouldn't avoid - OWise UK
Tamoxifen to prevent breast cancer? - Website for Liz O'Riordan
Tamoxifen Not Associated With Higher Risk for Cataracts in Women With DCIS - Oncology Nurse Advisor
Tamoxifen Helps Prevent Breast Cancer, but Women Reluctant to Take It
.jpg "Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis")
Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis
Gels | Free Full-Text | Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation
Practical Steps to Prevent Breast Cancer: Day 9 - If High Risk: Consider Risk-Reducing Medications | Public Health Sciences Division | Washington University in St. Louis
Combining Tamoxifen with Antidepressants: What You Need to Know
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial | Journal of Clinical Oncology
5 tips for scientific survival from the Father of Tamoxifen
Tamoxifen - the start of something big - Cancer Research UK - Cancer News
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 | Nature Communications
VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer | 2 Minute Medicine
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial - The Lancet
Medicina | Free Full-Text | Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms
mamo.cz - Tamoxifen class drugs reduce breast cancer rates by more than a third in women at high risk
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis - The Lancet Oncology
CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation: Molecular Therapy - Oncolytics
The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor–Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women - Value in Health Regional Issues
Why does tamoxifen work better in some women? | University of Michigan Rogel Cancer Center
Breast cancer treatment without tamoxifen drug - non prescription
Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework | SpringerLink
Why women reject breast cancer preventing drug – new study
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial - The Lancet
Cancers | Free Full-Text | TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer
